ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0866

Immunoglobulin from sera of patients with myositis can passively enter cultured human endothelial cells

Travis Kinder1, maria Casal-Dominguez1, Iago Pinal Fernandez2, Andrew Mammen3 and Sandra Ogbonnaya-Whittlesey4, 1National Institutes of Health, Bethesda, MD, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 3NIH, Bethesda, MD, 4NIH/NIAMS, Bethesda, MD

Meeting: ACR Convergence 2025

Keywords: immunology, Myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II: Basic & Translational Research (0861–0866)

Session Type: Abstract Session

Session Time: 11:15AM-11:30AM

Background/Purpose: Most patients with inflammatory myopathies have autoantibodies to intracellular proteins. We previously showed that immunoglobulin colocalizes with its cognate autoantigen in muscle biopsies from myositis patients. Transcriptomic analyses of muscle biopsy specimens revealed that each myositis autoantibody is associated with a unique transcriptomic profile.We confirmed that these effects are antibody-mediated by using electroporation to internalize antibodies from patients into cultured muscle cells. Cultured muscle cells with internalized immunoglobulin from anti-MDA5+ and anti-Mi2+ patients expressed the same genes (e.g., Mx1 and CAMKV, respectively) as seen in the muscle tissue. The aims of the current study were to: (i) determine if electroporation of myositis-associated antibodies into human endothelial cells has similar transcriptomic profile as seen in muscle and (ii) to determine if immunoglobulin could passively enter cultured endothelial cells without electroporation.

Methods: Electroporation of purified antibody from Healthy controls, MDA5+, and Mi2 + sera was performed in HUVECS. The cells were incubated for 24hrs at 37 degrees Celsius following electroporation in appropriate growth media. The RNA was extracted from the HUVECs and RNA to CT was performed for comparative, quantitative PCR using Mx1 and CAMKV as probes and an18S as an internal loading control to assess gene expression.For passive antibody uptake experiments, HUVECs were cultured for 24 hours in growth media with purified healthy control, Mi2 +, and MDA5 + immunoglobin at 6 different concentrations (1:3 titration). RNA was the extracted using RNEAsy kits. Taqman RNA to CT kit was used to perform comparative, quantitative PCR to measure MX1 gene expression relative to an 18S loading control.

Results: Electroporation of MDA5 antibody increased resulted in increased relative MX1 expression as measured by PCR and electroporation of Mi2 antibodies resulted in relatively increased CAMKV compared to MDA5 and Healthy controls, respectively (Figure 1).Purified concentrated, MDA5 IgG that was passively introduced via a 24-hour incubation resulted in significantly increased relative Mx1 expression compared to healthy control IgG or Mi2 IgG (Figure 2).

Conclusion: These results suggest that autoantibodies are able to enter the cultured endothelial cells both with electroporation and passively, without electroporation. The higher relative MX1 expression with internalization of purified immunoglobulin from MDA5 and Mi2 compared to healthy controls suggests that the antibodies themselves may be contributing to pathogenesis and that endothelial cells may be contributing to disease pathogenesis in some types of idiopathic inflammatory myositis. Additional work is ongoing to elucidate the mechanism for the antibodies passively entering the cells and reaching the antigenic target.

Supporting image 1

Supporting image 2


Disclosures: T. Kinder: None; m. Casal-Dominguez: None; I. Pinal Fernandez: None; A. Mammen: None; S. Ogbonnaya-Whittlesey: None.

To cite this abstract in AMA style:

Kinder T, Casal-Dominguez m, Pinal Fernandez I, Mammen A, Ogbonnaya-Whittlesey S. Immunoglobulin from sera of patients with myositis can passively enter cultured human endothelial cells [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/immunoglobulin-from-sera-of-patients-with-myositis-can-passively-enter-cultured-human-endothelial-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immunoglobulin-from-sera-of-patients-with-myositis-can-passively-enter-cultured-human-endothelial-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology